HYPOLIPIDEMIC MEDICATIONS: CURRENT USE AND FUTURE PERSPECTIVES. PART 1. NON-STATIN HYPOLIPIDEMIC MEDICATIONS

Abstract

This article is devoted to discussion about main aspects of current use of non-statin hypolipidemic drugs according last international guidelines (including fibrates, nicotinic acid, resins, polyunsaturated fatty acids, ezetimibe, PCSK9-inhibitors). For each group mechanism of action, effects on lipid profile, main results of randomized trials and practical use approaches are shortly represented.

Keywords

• non-statin hypolipidemic drugs
• fibrates
• nicotinic acid
• resins
• polyunsaturated fatty acids
• ezetimibe
• pcsk9-inhibitors